Search research articles
Contact Us
Filters
Showing results (251-260 of 456) with videos related to
Page
of 46
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1993
Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG
L M Peçanha, H Yamaguchi, A Lees, et al.
International Journal of Geriatric Psychiatry
|
August 17, 2016
Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items
Rosalind A Lees, Kirsty Hendry Ba, Niall Broomfield, et al.
Molecular and Cellular Biology
|
January 11, 2007
Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues
Tiziana Parisi, Tina L Yuan, Ann Marie Faust, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
February 5, 2004
The Vanguard endovascular stent-graft: mid-term results from a single centre
S J Holtham, J D G Rose, R W Jackson, et al.
Vaccine
|
January 29, 2000
Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides
D E Shafer, B Toll, R F Schuman, et al.
Vaccine
|
October 1, 1994
Enhanced immunogenicity of protein-dextran conjugates: I. Rapid stimulation of enhanced antibody responses to poorly immunogenic molecules
A Lees, F Finkelman, J K Inman, et al.
Cancer Cell
|
December 25, 2002
E2F4 loss suppresses tumorigenesis in Rb mutant mice
Eunice Y Lee, Hieu Cam, Ulrike Ziebold, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1990
Rapid stimulation of large specific antibody responses with conjugates of antigen and anti-IgD antibody
A Lees, S C Morris, G Thyphronitis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 23, 2000
What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?
G K Wenning, Y Ben-Shlomo, A Hughes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 1, 1990
Intranasal apomorphine: a new treatment in Parkinson's disease
R Kapoor, N Turjanski, J Frankel, et al.
Page
of 46
Search research articles
Search
Showing results (251-260 of 456) with videos related to
Sort By:
Page
of 46
Journal of Immunology (Baltimore, Md. : 1950)
|
March 15, 1993
Dextran-conjugated anti-IgD antibodies inhibit T cell-mediated IgE production but augment the synthesis of IgM and IgG
L M Peçanha, H Yamaguchi, A Lees, et al.
International Journal of Geriatric Psychiatry
|
August 17, 2016
Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items
Rosalind A Lees, Kirsty Hendry Ba, Niall Broomfield, et al.
Molecular and Cellular Biology
|
January 11, 2007
Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues
Tiziana Parisi, Tina L Yuan, Ann Marie Faust, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
February 5, 2004
The Vanguard endovascular stent-graft: mid-term results from a single centre
S J Holtham, J D G Rose, R W Jackson, et al.
Vaccine
|
January 29, 2000
Activation of soluble polysaccharides with 1-cyano-4-dimethylaminopyridinium tetrafluoroborate (CDAP) for use in protein-polysaccharide conjugate vaccines and immunological reagents. II. Selective crosslinking of proteins to CDAP-activated polysaccharides
D E Shafer, B Toll, R F Schuman, et al.
Vaccine
|
October 1, 1994
Enhanced immunogenicity of protein-dextran conjugates: I. Rapid stimulation of enhanced antibody responses to poorly immunogenic molecules
A Lees, F Finkelman, J K Inman, et al.
Cancer Cell
|
December 25, 2002
E2F4 loss suppresses tumorigenesis in Rb mutant mice
Eunice Y Lee, Hieu Cam, Ulrike Ziebold, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
December 1, 1990
Rapid stimulation of large specific antibody responses with conjugates of antigen and anti-IgD antibody
A Lees, S C Morris, G Thyphronitis, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 23, 2000
What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson's disease?
G K Wenning, Y Ben-Shlomo, A Hughes, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 1, 1990
Intranasal apomorphine: a new treatment in Parkinson's disease
R Kapoor, N Turjanski, J Frankel, et al.
Page
of 46